Table 1.
Demographic characteristics of study sample.
| Characteristic | Morning N = 90 | Bedtime N = 53 | P-value |
|---|---|---|---|
| AGE | |||
| Age range (Years) | 30–73 | 24–67 | |
| Age (mean ± SEM) | 53.46 ± 1.1 | 53.26 ± 1.2 | NS |
| Male sex, n (%) | 79 (87.7) | 49 (92.4) | NS |
| FOLLOW-UP PERIOD | |||
| Range (days) | 249–554 | 295–552 | |
| Observation days (Mean ± SEM) | 385 ± 6.1 | 400 ± 9.4 | NS |
| DIAGNOSIS | |||
| Psychotic disorder (%) | 11 (21) | 22 (24) | NS |
| Depressive disoder (%) | 28 (53) | 42 (47) | |
| Bipolar disorder (%) | 14 (26) | 26 (29) | |
| RACE | |||
| Caucasian, n (%) | 56 (62) | 31 (58) | NS |
| African American, n (%) | 17 (19) | 9 (17) | |
| Asian American, n (%) | 6 (7) | 6 (11) | |
| Other/Unknown, n (%) | 11 (12) | 6 (11) | |
| DOSE ARIPIPRAZOLE, N (%) | |||
| Average Dose (Mean ± SEM) | 15.2 ± 0.9 | 12.1 ± 1.3 | 0.05* |
| 2–5 mg, n (%) | 14 (16) | 27 (51) | |
| 10 mg, n (%) | 32 (36) | 9 (17) | |
| 15–20 mg, n (%) | 24 (27) | 8 (15) | |
| 30 mg, n (%) | 16 (18) | 9 (17) | |
| OTHER MEDICAL FACTORS | |||
| Diagnosis hypertension, n (%) | 51 (57) | 36 (68) | NS |
| Mirtazapine use, n (%) | 7 (8) | 4 (8) | NS |
| Metformin use, n (%) | 2 (2) | 0 (0) | NS |
| Statin use, n (%) | 7 (8) | 1 (2) | NS |